Correlation between fibroblast growth factor receptor mutation, programmed death ligand-1 expression and survival in urinary bladder cancer based on real-world data

Background: Programmed cell death (PD)-1/PD-ligand 1 (PD-L1) inhibitors have made a breakthrough in the therapy of advanced urothelial bladder cancer (UBC). The impact of Fibroblast Growth Factor Receptor 3 (FGFR3) mutation on the effectiveness of PD-L1 treatment remains still unclear. Objective: Ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Revesz, Janos, Posfai, Boglarka, Pajor, Laszlo, Papdan, Timea, Varga, Linda, Paczona, Viktor R., Varga, Zoltan, Sukosd, Farkas, Maraz, Aniko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160374/
https://www.ncbi.nlm.nih.gov/pubmed/37151354
http://dx.doi.org/10.3389/pore.2023.1611077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160374/
https://www.ncbi.nlm.nih.gov/pubmed/37151354
http://dx.doi.org/10.3389/pore.2023.1611077

Ejemplares similares